Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

被引:109
作者
Carralot, JP
Probst, J
Hoerr, I
Scheel, B
Teufel, R
Jung, G
Rammensee, HG
Pascolo, S
机构
[1] CureVac GmbH, D-72076 Tubingen, Germany
[2] Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany
[3] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany
关键词
vaccination; Th1/Th2; cell; rodent; gene therapy; messenger RNA; GM-CSF;
D O I
10.1007/s00018-004-4255-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked beta-globin untranslated region (UTR)-stabilized mRNA coding for beta-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant gramilocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
引用
收藏
页码:2418 / 2424
页数:7
相关论文
共 27 条
  • [1] Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization
    Cho, JH
    Lee, SW
    Sung, YC
    [J]. VACCINE, 1999, 17 (9-10) : 1136 - 1144
  • [2] Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
    Diebold, SS
    Kaisho, T
    Hemmi, H
    Akira, S
    Sousa, CRE
    [J]. SCIENCE, 2004, 303 (5663) : 1529 - 1531
  • [3] Technical and regulatory hurdles for DNA vaccines
    Donnelly, J
    Berry, K
    Ulmer, JB
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2003, 33 (5-6) : 457 - 467
  • [4] DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS
    FYNAN, EF
    WEBSTER, RG
    FULLER, DH
    HAYNES, JR
    SANTORO, JC
    ROBINSON, HL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11478 - 11482
  • [5] INDUCTION OF CROSS-REACTIVE ANTI-DSDNA ANTIBODIES IN PREAUTOIMMUNE NZB/NZW MICE BY IMMUNIZATION WITH BACTERIAL-DNA
    GILKESON, GS
    PIPPEN, AMM
    PISETSKY, DS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) : 1398 - 1402
  • [6] Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA
    Granstein, RD
    Ding, WH
    Ozawa, H
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (04) : 632 - 636
  • [7] Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
    Heil, F
    Hemmi, H
    Hochrein, H
    Ampenberger, F
    Kirschning, C
    Akira, S
    Lipford, G
    Wagner, H
    Bauer, S
    [J]. SCIENCE, 2004, 303 (5663) : 1526 - 1529
  • [8] Hoerr I, 2000, EUR J IMMUNOL, V30, P1
  • [9] Iwasaki A, 1997, J IMMUNOL, V158, P4591
  • [10] DNA vaccines: safety and efficacy issues
    Klinman, DM
    Takeno, M
    Ichino, M
    Gu, ML
    Yamshchikov, G
    Mor, G
    Conover, J
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (02): : 245 - 256